- Home
- INSP vs ARWR Comparison
INSP vs ARWR Comparison
Compare INSP & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSP
- ARWR
- Stock Information
- Founded
- INSP 2007
- ARWR 2003
- Country
- INSP United States
- ARWR United States
- Employees
- INSP N/A
- ARWR N/A
- Industry
- INSP Medical/Dental Instruments
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- INSP Health Care
- ARWR Health Care
- Exchange
- INSP Nasdaq
- ARWR Nasdaq
- Market Cap
- INSP 3.8B
- ARWR 2.5B
- IPO Year
- INSP 2018
- ARWR 1993
- Fundamental
- Price
- INSP $79.95
- ARWR $29.13
- Analyst Decision
- INSP Buy
- ARWR Strong Buy
- Analyst Count
- INSP 15
- ARWR 8
- Target Price
- INSP $165.86
- ARWR $47.75
- AVG Volume (30 Days)
- INSP 980.4K
- ARWR 2.8M
- Earning Date
- INSP 11-03-2025
- ARWR 08-07-2025
- Dividend Yield
- INSP N/A
- ARWR N/A
- EPS Growth
- INSP 756.73
- ARWR N/A
- EPS
- INSP 1.74
- ARWR N/A
- Revenue
- INSP $861,312,000.00
- ARWR $572,976,000.00
- Revenue This Year
- INSP $14.93
- ARWR $21,619.52
- Revenue Next Year
- INSP $14.34
- ARWR N/A
- P/E Ratio
- INSP $45.93
- ARWR N/A
- Revenue Growth
- INSP 22.05
- ARWR 2816.20
- 52 Week Low
- INSP $73.92
- ARWR $9.57
- 52 Week High
- INSP $218.52
- ARWR $31.13
- Technical
- Relative Strength Index (RSI)
- INSP 34.95
- ARWR 70.38
- Support Level
- INSP $79.27
- ARWR $28.12
- Resistance Level
- INSP $82.93
- ARWR $31.13
- Average True Range (ATR)
- INSP 3.93
- ARWR 1.58
- MACD
- INSP 0.34
- ARWR 0.12
- Stochastic Oscillator
- INSP 12.80
- ARWR 78.99
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.